Abstract Details

Title Assessment of Stroke Risk Factors in Southern Arizona

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P02 - (-)

Poster/Presentation
Number 054

Objective

Background BACKGROUND: Hispanics have a higher incidence of strokes and poorer prognosis than non-Hispanic whites. To determine the pertinent factors that should be considered for a stroke prevention program, attitudes toward stroke risk factors and preferences for obtaining health related information was collected.

Design/Methods DESIGN/METHODS: We collected 272 surveys (141 Hispanic, 131 non-Hispanic) in June 2012 containing quantitative and qualitative questions regarding chronic diseases, preferred sources of care, barriers to care, as well as the types of prevention programs potentially of interest to the patient population. All statistical analyses were performed using IBM SPSS.

Results RESULTS: Proportionately fewer Hispanic (7.7%) than non-Hispanic (16.9%) patients indicated that stroke was among the most important diseases affecting their community. Hispanics were less likely to consider stroke-associated risk factors such as cholesterol and hypertension to be problematic. However, Hispanics endorsed obesity, diabetes and heart disease as important health concerns. Hispanics were more likely to consult their provider for medical advice (p<0.05), preferred family involvement in healthcare decisions and were interested in programs that include nutritional education.

Conclusions CONCLUSIONS: Despite a higher incidence of stroke, Hispanic concern regarding stroke risk factors is much lower than non-Hispanics. This suggests that knowledge linking risk factors for stroke and incident stroke may be lacking in Hispanic communities. Lessened concern regarding stroke risk factors may contribute to an increase incidence in stroke and to a worse outcome in this population. Hispanics increased interest in health promotion programs may afford one approach to addressing this problem. This data suggest that despite historically worse stroke outcomes, preventative efforts may be beneficial in raising stroke risk factor awareness and improving outcomes in Hispanic patients.

Authors/Disclosures
Anatevka S. Ribeiro, MD PRESENTER	Dr. Ribeiro has nothing to disclose.
Jeffrey L. Bennett, MD, PhD, FAAN (University of Colorado School of Medicine)	Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Yeeck Sim, MD (Center for NeuroScience)	No disclosure on file
	No disclosure on file
	No disclosure on file
Kendra Drake, MD, FAAN (Western Neuro)	Dr. Drake has nothing to disclose.
David M. Labiner, MD (University of Arizona Health Sciences)	The institution of Dr. Labiner has received research support from CDC.
Bruce M. Coull, MD (Arizona Health Science Center)	Dr. Coull has nothing to disclose.

��ɫ��

��ɫ��